Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Scholar Rock Holding Corporation stock

Own Scholar Rock Holding Corporation stock in just a few minutes.

Fact checked

Scholar Rock Holding Corporation is a biotechnology business based in the US. Scholar Rock Holding Corporation shares (SRRK) are listed on the NASDAQ and all prices are listed in US Dollars. Scholar Rock Holding Corporation employs 93 staff and has a trailing 12-month revenue of around USD$19.5 million.

How to buy shares in Scholar Rock Holding Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Scholar Rock Holding Corporation. Find the stock by name or ticker symbol: SRRK. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Scholar Rock Holding Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Scholar Rock Holding Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Scholar Rock Holding Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Scholar Rock Holding Corporation share price

Use our graph to track the performance of SRRK stocks over time.

Scholar Rock Holding Corporation shares at a glance

Information last updated 2021-02-23.
52-week rangeUSD$10.09 - USD$66.718
50-day moving average USD$54.7515
200-day moving average USD$35.1283
Wall St. target priceUSD$66.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.947

Buy Scholar Rock Holding Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Scholar Rock Holding Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Scholar Rock Holding Corporation financials

Revenue TTM USD$19.5 million
Gross profit TTM USD$-33,725,000
Return on assets TTM -25.97%
Return on equity TTM -77.38%
Profit margin 0%
Book value $2.105
Market capitalisation USD$1.7 billion

TTM: trailing 12 months

Shorting Scholar Rock Holding Corporation shares

There are currently 1.4 million Scholar Rock Holding Corporation shares held short by investors – that's known as Scholar Rock Holding Corporation's "short interest". This figure is 9.4% down from 1.5 million last month.

There are a few different ways that this level of interest in shorting Scholar Rock Holding Corporation shares can be evaluated.

Scholar Rock Holding Corporation's "short interest ratio" (SIR)

Scholar Rock Holding Corporation's "short interest ratio" (SIR) is the quantity of Scholar Rock Holding Corporation shares currently shorted divided by the average quantity of Scholar Rock Holding Corporation shares traded daily (recently around 229276.61691542). Scholar Rock Holding Corporation's SIR currently stands at 6.03. In other words for every 100,000 Scholar Rock Holding Corporation shares traded daily on the market, roughly 6030 shares are currently held short.

However Scholar Rock Holding Corporation's short interest can also be evaluated against the total number of Scholar Rock Holding Corporation shares, or, against the total number of tradable Scholar Rock Holding Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Scholar Rock Holding Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Scholar Rock Holding Corporation shares in existence, roughly 40 shares are currently held short) or 0.0709% of the tradable shares (for every 100,000 tradable Scholar Rock Holding Corporation shares, roughly 71 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Scholar Rock Holding Corporation.

Find out more about how you can short Scholar Rock Holding Corporation stock.

Scholar Rock Holding Corporation share dividends

We're not expecting Scholar Rock Holding Corporation to pay a dividend over the next 12 months.

Scholar Rock Holding Corporation share price volatility

Over the last 12 months, Scholar Rock Holding Corporation's shares have ranged in value from as little as $10.09 up to $66.718. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Scholar Rock Holding Corporation's is 0.315. This would suggest that Scholar Rock Holding Corporation's shares are less volatile than average (for this exchange).

Scholar Rock Holding Corporation overview

Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, a novel inhibitor of the activation of myostatin, which is in Phase II clinical trials for the treatment of spinal muscular atrophy. The company is also developing SRK-181, which is in Phase I clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1. In addition, it is developing a pipeline of novel product candidates for a range of serious diseases, including neuromuscular disorders, cancer, fibrosis, and anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site